News and Announcements
Jardine Pharmaceuticals to launch new products in Australia and NZ
- Published January 05, 2015 10:49AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
As presented at the November 2014 Wholesale Investor Capital Expo’s in Singapore, Sydney and Melbourne, Jardine was on target for the December launch of the TGA Listed Polypill capsules in Australia and NZ.
Polypill – Joint and Polypill – Heart have hit the shelves!
The introduction of modified oak polyphenols into the marketplace begins a new era in the burgeoning field of life extension!
Quercus robur (French oak) is traditionally used in European medicine to help restore vitality in ageing. Emerging scientific evidence indicates that it is the complexed pyrogallols in the oak that are potent antioxidants and anti-inflammatories.
With our patented technology, we have managed to extract these compounds from the oak in a bioavailable and very efficacious form and combine them into capsules to help relieve some of the symptoms of ageing. The prebiotic effect of this unique extract may help to maintain metabolic health.
POLYPILL – JOINT:
Formulated to provide the temporary relief of the pain of osteoarthritis and help reduce joint inflammation associated with arthritis.
POLYPILL – HEART:
Formulated to help maintain metabolic health, to assist in blood lipid balance and the maintenance of normal blood pressure in healthy individuals.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
